Deepika Pakianathan - Insider Trading & Ownership

Location
160 Bovet Road, Suite 408, C/O Delphi Ventures, San Mateo, CA
Summary
The estimated net worth of Deepika Pakianathan is at least $622K dollars as of May 29, 2025. Deepika Pakianathan is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $566K. Deepika Pakianathan is the Director of Mereo BioPharma Group plc and owns shares of Mereo BioPharma Group plc (MREO) stock worth about $55.6K.
Signature
/s/ Nancy Smith, Attorney-in-Fact for Deepika Pakianathan
All Insider Reports
All Insider Reports

Ownership of Deepika Pakianathan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $566K May 19, 2025
MREO Mereo BioPharma Group plc Director $55.6K Feb 5, 2025
KPTI Karyopharm Therapeutics Inc. Director $0 May 28, 2025
CALA Calithera Biosciences, Inc. Director Jan 27, 2023
PRDS PARDES BIOSCIENCES, INC. Director Dec 23, 2021

Insider Transactions Reported by Deepika Pakianathan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.